ARCHIVES

Controversial Toxicology Protocol Is “Getting The Information We Need;” Additionally Revision Made

This article is from The Cancer Letter archive.

Vol. 10 No. 09 | March 2, 1984

Download PDF Visit The Full Archive

Related Articles

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012

SBRT Delivers Higher Overall Survival Rates Compared to Conventional Radiation Therapy

November 30, 2012

AACR, NCCR Advocate Five-Year Plan to Reach $10 billion Annual Cancer Budget

April 30, 1999

In Brief: House Money Bill Reportedly Will Not Increase

September 18, 1981

Bristol-Myers Adds UCLA, Fox Chase To Grants Program

April 12, 1985

Nutrition RFPs Will Really Be Grants, Gori Says

January 23, 1976